Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Europe Digital Genome Market Forecast 2021-2028

Published by Inkwood Research Product code 991379
Published Content info 143 Pages
Delivery time: 2-3 business days
Price
Back to Top
Europe Digital Genome Market Forecast 2021-2028
Published: March 1, 2021 Content info: 143 Pages
Description

KEY FINDINGS

The Europe digital genome market is anticipated to record a CAGR of 9.16%, across the forecast years of 2021 to 2028. The launch of innovative technologies for genome projects, the increasing number of genome researches conducted, and the rising government and private funding for genome sequencing, essentially fuel the region's market growth.

MARKET INSIGHTS

The Europe digital genome market growth is determined by analyzing Italy, France, the United Kingdom, Belgium, Russia, Poland, Germany, and the rest of Europe. Germany is regarded as one of the most extensive hubs for biotechnology across Europe, and globally. The prominence is attributed to the widespread prevalence of leading biotechnology firms, the massive funding for conducting research and development, and high-tech research labs. The country also headquarters more biotechnology companies than other countries in Europe. Moreover, the high-quality research in Germany results in lucrative opportunities, and therefore, a well-established digital genome market.

On the other hand, the augmenting genomic research for agriculture is projected to favor the digital genome market growth in Italy. The Genomics Research Centre of Fiorenzuola d'Arda is part of the Consiglio per la ricerca in agricoltura e l'analisi dell'economia agraria (CREA). It operates under the authority and supervision of Italy's Ministry of Agriculture, and possesses expertise in fields like bioinformatics, proteomics, and plant genomics. The center's research endeavors concentrate on the structure, comprehension, and function of genes and their products, increasing food safety, security, quality, and genetically improvising crop species. Hence, these factors are set to propel the market growth in Europe, across the forecast period.

COMPETITIVE INSIGHTS

Some of the eminent companies operating in the market are, Biomerieux SA, Thermo Fisher Scientific Inc, Qiagen, F. Hoffman-La Roche Ltd, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 36135

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. INCREASING FUNDING BY THE MANUFACTURERS AND GOVERNMENTS IN GENOMICS
    • 3.1.2. ADVANCEMENTS IN TECHNOLOGY
    • 3.1.3. SURGING PREVALENCE OF CHRONIC DISEASES
  • 3.2. KEY RESTRAINTS
    • 3.2.1. RISKS ASSOCIATED WITH SECURITY ISSUE OF DIGITAL GENOME
    • 3.2.2. LACK OF PROFESSIONALS WITH ADEQUATE KNOWLEDGE ABOUT THE GENOMIC TECHNOLOGY

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCES ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. IMPACT OF COVID-19 ON DIGITAL GENOME MARKET
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY PRODUCT

  • 5.1. SEQUENCING AND ANALYZER INSTRUMENTS
  • 5.2. DNA/RNA ANALYSIS
  • 5.3. SEQUENCING AND ANALYSIS SOFTWARE
  • 5.4. SEQUENCING CHIPS
  • 5.5. SAMPLE PREP INSTRUMENTS

6. MARKET BY APPLICATION

  • 6.1. DIAGNOSTICS
  • 6.2. DRUG DISCOVERY
  • 6.3. ACADEMIC RESEARCH
  • 6.4. PERSONALIZED MEDICINE
  • 6.5. AGRICULTURAL
  • 6.6. OTHER APPLICATIONS

7. MARKET BY END-USER

  • 7.1. DIAGNOSTICS AND FORENSIC LABS
  • 7.2. ACADEMIC RESEARCH INSTITUTES
  • 7.3. HOSPITALS
  • 7.4. OTHER END-USERS

8. GEOGRAPHICAL ANALYSIS

  • 8.1. EUROPE
    • 8.1.1. MARKET SIZE & ESTIMATES
    • 8.1.2. KEY GROWTH ENABLERS
    • 8.1.3. KEY CHALLENGES
    • 8.1.4. KEY PLAYERS
    • 8.1.5. COUNTRY ANALYSIS
      • 8.1.5.1. GERMANY
      • 8.1.5.2. FRANCE
      • 8.1.5.3. UNITED KINGDOM
      • 8.1.5.4. ITALY
      • 8.1.5.5. RUSSIA
      • 8.1.5.6. BELGIUM
      • 8.1.5.7. POLAND
      • 8.1.5.8. REST OF EUROPE

9. COMPETITIVE LANDSCAPE

  • 9.1. KEY STRATEGIC DEVELOPMENTS
    • 9.1.1. MERGER & ACQUISITIONS
    • 9.1.2. PRODUCT LAUNCH & DEVELOPMENTS
    • 9.1.3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
    • 9.1.4. BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
  • 9.2. COMPANY PROFILE
    • 9.2.1. ABBOTT LABORATORIES
    • 9.2.2. AGILENT TECHNOLOGIES INC.
    • 9.2.3. BECTON, DICKINSON AND COMPANY (BD)
    • 9.2.4. BIOMERIEUX SA
    • 9.2.5. BIO-RAD LABORATORIES INC
    • 9.2.6. F. HOFFMANN-LA ROCHE
    • 9.2.7. ILLUMINA INC
    • 9.2.8. INSCRIPTA
    • 9.2.9. OXFORD NANOPORE TECHNOLOGIES LTD
    • 9.2.10. PACIFIC BIOSCIENCE
    • 9.2.11. PERKINELMER INC
    • 9.2.12. QIAGEN NV
    • 9.2.13. REGENERON PHARMACEUTICALS
    • 9.2.14. THERMO FISHER SCIENTIFIC INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - DIGITAL GENOME
  • TABLE 2: EUROPE DIGITAL GENOME MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: EUROPE DIGITAL GENOME MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: EUROPE DIGITAL GENOME MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: EUROPE DIGITAL GENOME MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: EUROPE DIGITAL GENOME MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: EUROPE DIGITAL GENOME MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: EUROPE DIGITAL GENOME MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: EUROPE DIGITAL GENOME MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: LEADING PLAYERS OPERATING IN EUROPE DIGITAL GENOME MARKET

LIST OF FIGURES

  • FIGURE 1: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 2: OPPORTUNITY MATRIX
  • FIGURE 3: VENDOR LANDSCAPE
  • FIGURE 4: KEY INVESTMENT INSIGHTS
  • FIGURE 5: EUROPE DIGITAL GENOME MARKET, BY PRODUCT, IN 2020
  • FIGURE 6: EUROPE DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYZER INSTRUMENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 7: EUROPE DIGITAL GENOME MARKET, BY DNA/RNA ANALYSIS, 2021-2028 (IN $ MILLION)
  • FIGURE 8: EUROPE DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYSIS SOFTWARE, 2021-2028 (IN $ MILLION)
  • FIGURE 9: EUROPE DIGITAL GENOME MARKET, BY SEQUENCING CHIPS, 2021-2028 (IN $ MILLION)
  • FIGURE 10: EUROPE DIGITAL GENOME MARKET, BY SAMPLE PREP INSTRUMENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 11: EUROPE DIGITAL GENOME MARKET, BY APPLICATION, IN 2020
  • FIGURE 12: EUROPE DIGITAL GENOME MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)
  • FIGURE 13: EUROPE DIGITAL GENOME MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)
  • FIGURE 14: EUROPE DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH, 2021-2028 (IN $ MILLION)
  • FIGURE 15: EUROPE DIGITAL GENOME MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)
  • FIGURE 16: EUROPE DIGITAL GENOME MARKET, BY AGRICULTURAL, 2021-2028 (IN $ MILLION)
  • FIGURE 17: EUROPE DIGITAL GENOME MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 18: EUROPE DIGITAL GENOME MARKET, BY END-USER, IN 2020
  • FIGURE 19: EUROPE DIGITAL GENOME MARKET, BY DIAGNOSTICS AND FORENSIC LABS, 2021-2028 (IN $ MILLION)
  • FIGURE 20: EUROPE DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
  • FIGURE 21: EUROPE DIGITAL GENOME MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
  • FIGURE 22: EUROPE DIGITAL GENOME MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)
  • FIGURE 23: EUROPE DIGITAL GENOME MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 24: GERMANY DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 25: FRANCE DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 26: UNITED KINGDOM DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 27: ITALY DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 28: RUSSIA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 29: BELGIUM DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 30: POLAND DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 31: REST OF EUROPE DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
Back to Top